• Menu
  • Skip to right header navigation
  • Skip to main content
  • Skip to primary sidebar

Before Header

Call us today at (720) 328-8501Go to Prospect Life Sciences LinkedIn page Client Login

Prospect Life Sciences

Prepare to Prosper

  • WHAT WE DO
    • Devices We Make
    • NPI Services
    • Production Services
    • Fulfillment Services
    • À La Carte Services
  • HOW WE DO IT
    • Contract Manufacturing Solutions
    • Supply Chain Management
    • Quality Systems Management
    • Project Management
    • Onsite Features
    • Partnerships & Grant Support
  • THE PLS DIFFERENCE
    • Core Values
    • Our Team
    • Why People Like Us
  • NEWS & EVENTS
  • NOW HIRING
  • CONTACT US
  • What We Do
    • Devices We Make
    • NPI Services
    • Production Services
  • How We Do It
    • Supply Chain Management
    • Quality Systems Management
    • Project Management
    • Onsite Features
    • Partnerships and Grant Support
  • The PLS Difference
  • News & Events
  • Contact Us

Spinal Stabilization Technologies in LOPAIN2 Trial

December 10, 2022 By //  by PLS

Congratulations to Spinal Stabilization Technologies on beginning their LOPAIN2 clinical trial, measuring the efficacy of the PerQdisc Nucleus Replacement Device (NRD).

Filed Under: news

Previous Post: «StimSite medical device Allotrope Medical, Inc. Earns FDA Safer Technologies Program (STeP) Designation
Next Post: Visit PLS at MD&M West »

Copyright © 2023 Prospect Life Sciences · All rights reserved. View our Privacy Policy.